In contrast, levels of antibodies against tau protein (IgG), S100B (IgG), NMDA receptor (IgA), enteric nerve (IgG), amyloid β peptide (IgG), and GAD-65 (IgG) were lower in the sera of COVID-19 patients. This evidence concerns the gene CD79A and COVID-19.